Zydus Pharmaceuticals (USA) Inc. is voluntarily recalling 8,784 bottles of Entecavir (entecavir), a prescription medication used to treat chronic hepatitis B. The recall was initiated because the tablets failed to meet required specifications for impurities and degradation during testing. Consumers who have these tablets should contact their healthcare provider or pharmacist regarding their treatment.
The presence of impurities or degradation products beyond approved limits may reduce the effectiveness of the medication or cause unexpected side effects over time.
You have 2 options:
Recall #: D-0656-2025; Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India
Recall #: D-0657-2025; Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.